390 related articles for article (PubMed ID: 27180571)
21. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack.
Kavitha N; Noordin R; Chan KL; Sasidharan S
BMC Complement Altern Med; 2012 Jul; 12():91. PubMed ID: 22781137
[TBL] [Abstract][Full Text] [Related]
22. Ketolide ABT-773 is active against Toxoplasma gondii.
Khan AA; Araujo FG; Craft JC; Remington JS
J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
[TBL] [Abstract][Full Text] [Related]
23. Action of a pentacyclic triterpenoid, maslinic acid, against Toxoplasma gondii.
De Pablos LM; González G; Rodrigues R; García Granados A; Parra A; Osuna A
J Nat Prod; 2010 May; 73(5):831-4. PubMed ID: 20441162
[TBL] [Abstract][Full Text] [Related]
24. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
[TBL] [Abstract][Full Text] [Related]
25. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
26. In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.
Abugri DA; Witola WH; Jaynes JM
Parasitol Res; 2017 Dec; 116(12):3387-3400. PubMed ID: 29086004
[TBL] [Abstract][Full Text] [Related]
27. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and in vitro anti-Toxoplasma gondii activity of a new series of aryloxyacetophenone thiosemicarbazones.
Ansari M; Montazeri M; Daryani A; Farshadfar K; Emami S
Mol Divers; 2020 Nov; 24(4):1223-1234. PubMed ID: 31485890
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Toxoplasma gondii and Plasmodium falciparum infections in vitro by NSC3852, a redox active antiproliferative and tumor cell differentiation agent.
Strobl JS; Seibert CW; Li Y; Nagarkatti R; Mitchell SM; Rosypal AC; Rathore D; Lindsay DS
J Parasitol; 2009 Feb; 95(1):215-23. PubMed ID: 18837587
[TBL] [Abstract][Full Text] [Related]
30. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
[TBL] [Abstract][Full Text] [Related]
31. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
32. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
33. The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures.
Kropf C; Debache K; Rampa C; Barna F; Schorer M; Stephens CE; Ismail MA; Boykin DW; Hemphill A
Parasitology; 2012 Feb; 139(2):208-20. PubMed ID: 22011664
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity.
Tenório RP; Carvalho CS; Pessanha CS; de Lima JG; de Faria AR; Alves AJ; de Melo EJ; Góes AJ
Bioorg Med Chem Lett; 2005 May; 15(10):2575-8. PubMed ID: 15863319
[TBL] [Abstract][Full Text] [Related]
35. In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against
Ma Y; Cao X; Wang H; Song X; Hu D
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076987
[No Abstract] [Full Text] [Related]
36. Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-
Guo HY; Jin C; Zhang HM; Jin CM; Shen QK; Quan ZS
J Agric Food Chem; 2019 Aug; 67(34):9630-9642. PubMed ID: 31365255
[TBL] [Abstract][Full Text] [Related]
37. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Strobl JS; Cassell M; Mitchell SM; Reilly CM; Lindsay DS
J Parasitol; 2007 Jun; 93(3):694-700. PubMed ID: 17626366
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles.
Liesen AP; de Aquino TM; Carvalho CS; Lima VT; de Araújo JM; de Lima JG; de Faria AR; de Melo EJ; Alves AJ; Alves EW; Alves AQ; Góes AJ
Eur J Med Chem; 2010 Sep; 45(9):3685-91. PubMed ID: 20541294
[TBL] [Abstract][Full Text] [Related]
39. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
40. In Vitro and In Vivo Activities of Sulfur-Containing Linear Bisphosphonates against Apicomplexan Parasites.
Szajnman SH; Galaka T; Li ZH; Li C; Howell NM; Chao MN; Striepen B; Muralidharan V; Moreno SN; Rodriguez JB
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
